Saks Samuel R
Insider CIK 1365615 · DEPO Director · PTGX Chief Medical Officer · TNXP Director · ASPX Chief Development Officer, Director · PDLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-02-26 | 2021-02-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2021-02-26 | 2021-02-26 | 12,000 | — | $0 | 14,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-02-28 | 2020-02-28 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-06-20 | 2019-06-24 | 126,050 | $3.00 | $378.1K | 126,050 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-05-15 | 2019-05-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-02-28 | 2019-03-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2019-02-28 | 2019-03-04 | 2,500 | — | $0 | 2,500 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2018-06-12 | 2018-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2018-06-08 | 2018-06-12 | 54,348 | $2.76 | $150.0K | 214,190 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-05-31 | 2018-05-31 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2017-06-20 | 2017-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2017-06-09 | 2017-06-12 | 60,729 | $2.47 | $150.0K | 159,842 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | M Exercise deriv | 2017-05-27 | 2018-03-09 | 750 | — | $0 | 0 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | M Exercise | 2017-05-27 | 2018-03-09 | 750 | — | $0 | 6,605 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | M Exercise deriv | 2017-02-09 | 2018-03-09 | 750 | — | $0 | 0 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | M Exercise | 2017-02-09 | 2018-03-09 | 750 | — | $0 | 5,855 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2016-06-21 | 2016-06-21 | 25,000 | $2.00 | $50.0K | 63,550 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2016-06-21 | 2016-06-29 | 12,500 | $2.00 | $25.0K | 51,050 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2016-06-02 | 2016-06-03 | 71,023 | $3.52 | $250.0K | 99,113 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2016-05-27 | 2016-05-31 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2016-05-18 | 2016-05-20 | 7,669 | — | $0 | 7,669 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2016-05-18 | 2016-05-20 | 3,131 | — | $0 | 3,131 | SEC↗ |
| DEPO DEPOMED INC | F Tax w/h | 2016-05-12 | 2016-05-13 | 734 | $17.52 | $12.9K | 5,099 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | M Exercise deriv | 2016-02-25 | 2018-03-09 | 650 | — | $0 | 0 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | M Exercise | 2016-02-25 | 2018-03-09 | 600 | — | $0 | 3,855 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2016-02-09 | 2016-02-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DEPO DEPOMED INC | F Tax w/h | 2015-12-01 | 2015-12-03 | 966 | $19.00 | $18.4K | 2,897 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-09-14 | 2015-09-16 | 28,090 | $5.34 | $150.0K | 28,090 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2015-07-17 | 2015-07-17 | 10,000 | $7.50 | $75.0K | 32,550 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2015-05-12 | 2015-05-13 | 7,857 | — | $0 | 7,857 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2015-05-12 | 2015-05-13 | 2,936 | — | $0 | 2,936 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 27,235 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 47,777 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 7,777 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 30,000 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer deriv | 2015-05-05 | 2015-05-06 | 15,000 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-06 | 67,338 | — | $0 | 0 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2015-02-25 | 2015-02-27 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2015-02-25 | 2015-02-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | A Award deriv | 2015-02-02 | 2015-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | A Award deriv | 2015-02-02 | 2015-02-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2014-12-01 | 2014-12-12 | 9,852 | — | $0 | 9,852 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2014-12-01 | 2014-12-12 | 3,863 | — | $0 | 3,863 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2014-10-29 | 2014-10-31 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2014-06-17 | 2014-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2014-02-11 | 2014-02-26 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-12 | 2,175 | $12.00 | $26.1K | 63,839 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2013-12-10 | 2013-12-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy deriv | 2013-08-14 | 2013-08-15 | 5,883 | — | $0 | 5,883 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | P Buy | 2013-08-14 | 2013-08-15 | 5,883 | — | $0 | 22,550 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | C Conversion deriv | 2013-04-26 | 2013-04-29 | 166,667 | — | $0 | 166,667 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | C Conversion | 2013-04-26 | 2013-04-29 | 166,667 | $0.40 | $66.7K | 333,334 | SEC↗ |
| TNXP Tonix Pharmaceuticals Hold | A Award deriv | 2013-02-12 | 2013-03-01 | 210,000 | — | $0 | 0 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2012-10-08 | 2012-10-09 | 40,000 | — | $0 | 40,000 | SEC↗ |